{
  "case_id": "case_0057",
  "provider": "openai",
  "status": "processed",
  "patient_demographics": {
    "age": 36.32,
    "sex": "Male",
    "genderIdentity": "Cisgender Female",
    "ancestry": "Sub-Saharan African"
  },
  "marking_output": {
    "Localisation": {
      "report_string": "--- Localisation ---\nAgree with lesion involving:\n- left optic nerve.",
      "structured_data": {
        "gt_lesions_english": [
          "left optic nerve (cranial nerve II)"
        ],
        "ft_lesions_parsed": [
          {
            "location": "optic nerve",
            "side": "left",
            "qualifier": null
          }
        ],
        "exact_matches": [
          "left optic nerve (cranial nerve II)"
        ],
        "imprecise_matches": [],
        "missing_lesions_from_ft": [],
        "additional_lesions_in_ft": []
      },
      "scoring": {
        "gt_lesion_count": 1,
        "correctly_identified_count": 1,
        "imprecisely_identified_count": 0,
        "missed_lesion_count": 0,
        "additional_lesion_count": 0,
        "proportion_correct": 1.0,
        "proportion_imprecise": 0.0,
        "proportion_missed": 0.0,
        "proportion_additional": 0.0
      }
    },
    "Differential diagnosis": {
      "report_string": "--- Differential diagnosis ---\nCorrectly included Multiple sclerosis.\n\nAgree to also consider:\n- NMOSD (AQP4+), MOGAD, Neurosarcoid, Neurosyphilis, Compressive Optic Neuropathy and Lyme.\n\nOther possible differentials:\n- SLE, Bartonella and Retinal Detachment.\n- Also feasible but of low probability: TB, Beh\u00e7et's, Lymphoma, Vasculitis, Sjogren's and Leber's Hereditary Optic Neuropathy.\n\nThe following suggested diagnoses have a low probability of providing a unifying explanation for the full clinical presentation:\n- Non-arteritic anterior ischaemic optic neuropathy (atypical for age, usually > 50)\n- Toxic or nutritional optic neuropathy (atypical for strictly unilateral optic nerve involvement)",
      "structured_data": {
        "ft_diagnoses_raw": [
          "Typical demyelinating optic neuritis associated with multiple sclerosis",
          "Neuromyelitis optica spectrum disorder\u2013associated optic neuritis",
          "Myelin oligodendrocyte glycoprotein (MOG) antibody\u2013associated optic neuritis",
          "Non-arteritic anterior ischaemic optic neuropathy",
          "Compressive optic neuropathy (e.g., optic nerve sheath meningioma)",
          "Inflammatory or infectious optic neuropathy (e.g., sarcoidosis, syphilis, Lyme disease)",
          "Toxic or nutritional optic neuropathy"
        ],
        "gt_diagnoses_with_source": {
          "Multiple sclerosis": "evaluation"
        },
        "correctly_mentioned_original_gt": [
          "Multiple sclerosis"
        ],
        "missing_original_gt": [],
        "matched_lesion_dx_keys": [
          "Compressive_Optic_Neuropathy",
          "MOGAD",
          "Syphilis",
          "AQP4_NMOSD",
          "Neurosarcoidosis",
          "MS",
          "Infection_Lyme"
        ],
        "missing_lesion_dx_keys": [
          "CNS_Tuberculosis",
          "Bartonella_Henselae",
          "Idiopathic_Optic_Neuritis",
          "Behcet_Disease",
          "Retinal_Detachment",
          "CNS_Lymphoma",
          "CNS_Vasculitis",
          "Autoimmune_Myelitis_Sjogren",
          "Autoimmune_Myelitis_SLE",
          "Optic_Neuropathy_Nonspecific",
          "Leber_Hereditary_Optic_Neuropathy"
        ],
        "missing_common_names": [
          "Bartonella",
          "Retinal Detachment",
          "SLE"
        ],
        "missing_low_prob_names": [
          "TB",
          "Beh\u00e7et's",
          "Lymphoma",
          "Vasculitis",
          "Sjogren's",
          "Leber's Hereditary Optic Neuropathy"
        ],
        "additional_diagnoses": [
          "Non-arteritic anterior ischaemic optic neuropathy",
          "Toxic or nutritional optic neuropathy"
        ]
      },
      "scoring": {
        "primary_diagnosis_included": 1,
        "primary_diagnosis_name": "Multiple sclerosis",
        "gt_total_count": 1,
        "gt_matched_count": 1,
        "gt_missed_count": 0,
        "gt_coverage_percentage": 1.0,
        "additional_less_plausible_count": 2,
        "comorbidity_missing_count": 0,
        "other_considerations_missed_count": 0,
        "lesion_ddx_total_count": 18,
        "lesion_ddx_matched_count": 7,
        "lesion_ddx_missed_common_count": 3,
        "lesion_ddx_missed_low_prob_count": 6,
        "lesion_ddx_coverage_percentage": 0.3888888888888889
      }
    },
    "Investigations": {
      "report_string": "--- Investigations ---\n\n- Agree with the suggested MRI including the Brain and Orbits and CSF test for Oligoclonal Bands - would potentially inform a diagnosis/details of multiple sclerosis.\n\nTo evaluate other differential diagnoses:\n- Agree with considering: anti-MOG, ANA, CRP, ENA, ACE, HIV, anti-AQP4, syphilis, ESR, lyme.\n- Could also consider testing: anti-dsDNA, bartonella, TB, ANCA, CSF (flow cytometry and cytology).",
      "structured_data": {
        "gt_required_tests_primary": [
          {
            "type": "CSF",
            "detail": "Oligoclonal Bands",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "MRI",
            "region": "Orbits",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "MRI",
            "region": "Brain",
            "condition": "Multiple sclerosis"
          }
        ],
        "ft_proposed_investigations": [
          "MRI of brain and orbits with gadolinium",
          "Automated visual field testing (perimetry)",
          "Optical coherence tomography of retinal nerve fibre layer",
          "Visual evoked potentials",
          "Full blood count",
          "Urea and electrolytes",
          "Liver function tests",
          "C-reactive protein",
          "Erythrocyte sedimentation rate",
          "Blood glucose",
          "Serum vitamin B12",
          "Serum folate",
          "Serum aquaporin-4 IgG antibody",
          "Serum MOG IgG antibody",
          "Antinuclear antibody",
          "Extractable nuclear antigen panel",
          "Serum angiotensin-converting enzyme",
          "Syphilis serology (treponemal test and non-treponemal test)",
          "HIV antigen/antibody test",
          "Lyme disease serology",
          "Lumbar puncture with CSF analysis including oligoclonal bands and IgG index",
          "Chest CT if sarcoidosis is suspected on other grounds"
        ],
        "all_identified_ft_keys": [
          "MOG_Antibodies",
          "CRP",
          "ENA_Panel",
          "LFT",
          "MRI_Orbits",
          "Vitamin_B12",
          "Serum_ACE",
          "Glucose_HbA1c",
          "CSF_Oligoclonal_Bands",
          "U_and_E",
          "AQP4_Antibodies",
          "Syphilis_Serology",
          "Lyme_Serology",
          "CSF_General",
          "FBC",
          "ANA",
          "Chest_CT",
          "OCT",
          "Chest_XRay",
          "Folate",
          "HIV_Test",
          "Serum_Immunoglobulins",
          "VEP",
          "MRI_Brain",
          "ESR",
          "Automated_Visual_Fields"
        ],
        "found_tests_primary": [
          {
            "type": "MRI",
            "region": "Orbits",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "MRI",
            "region": "Brain",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "CSF",
            "detail": "Oligoclonal Bands",
            "condition": "Multiple sclerosis"
          }
        ],
        "missing_tests_primary": [],
        "expected_inv_keys_ddx": [
          "Anti_dsDNA",
          "CSF_Flow_Cytometry",
          "ANA",
          "CRP",
          "MOG_Antibodies",
          "Bartonella_Serology",
          "TB_Screen",
          "ENA_Panel",
          "Serum_ACE",
          "HIV_Test",
          "ANCA",
          "CSF_Cytology",
          "AQP4_Antibodies",
          "Syphilis_Serology",
          "ESR",
          "Lyme_Serology"
        ],
        "found_inv_keys_ddx": [
          "MOG_Antibodies",
          "ANA",
          "CRP",
          "ENA_Panel",
          "Serum_ACE",
          "HIV_Test",
          "AQP4_Antibodies",
          "Syphilis_Serology",
          "ESR",
          "Lyme_Serology"
        ],
        "missing_inv_keys_ddx": [
          "Anti_dsDNA",
          "CSF_Flow_Cytometry",
          "Bartonella_Serology",
          "TB_Screen",
          "ANCA",
          "CSF_Cytology"
        ]
      },
      "scoring": {
        "primary_tests_required_count": 3,
        "primary_tests_found_count": 3,
        "primary_tests_missed_count": 0,
        "primary_tests_coverage_percentage": 1.0,
        "ddx_tests_expected_count": 16,
        "ddx_tests_found_count": 10,
        "ddx_tests_coverage_percentage": 0.625
      }
    },
    "Management": {
      "report_string": "--- Management ---\nSteroids: Not appropriate to start treatment immediately.\n  \nCorrectly identified the following:\n\n- Need to know comorbidities to ensure no contraindications to immunosuppression.\n  \nAdditional factors not mentioned:\n\n- This could be a pseudorelapse (exacerbation of an old deficit) rather than a new acute inflammatory relapse, need further clarity in the history of presenting complaint.\n\nDMTs: Appropriate to consider but delay treatment.\n  \nCorrectly identified the following:\n\n- Need confirmation of MS diagnosis.\n  \nAdditional factors not mentioned:\n\n- Need to know comorbidities to ensure no contraindications to immunosuppression.",
      "structured_data": {
        "ft_full_plan_parsed": [
          {
            "treatment": "Intravenous methylprednisolone 1 g daily for 3\u20135 days followed by a short oral prednisolone taper",
            "timing": "Start Now",
            "reasons": [
              "First-line therapy for acute inflammatory demyelinating optic neuritis",
              "Can hasten visual recovery even though final visual outcome may be similar without treatment",
              "Helps treat potential NMOSD or MOG-antibody\u2013associated optic neuritis where early immunosuppression is important",
              "No evidence from current data of active infection or other contraindications to high-dose steroids"
            ]
          },
          {
            "treatment": "Proton pump inhibitor for gastric protection while receiving high-dose corticosteroids",
            "timing": "Start Now",
            "reasons": [
              "High-dose intravenous and oral steroids increase risk of gastritis and peptic ulcer disease",
              "Simple measure to reduce upper gastrointestinal adverse events during steroid course"
            ]
          },
          {
            "treatment": "Monitoring and prophylaxis for steroid-related adverse effects (blood pressure and blood glucose monitoring, venous thromboembolism risk assessment and prophylaxis as appropriate)",
            "timing": "Start Now",
            "reasons": [
              "High-dose steroids can precipitate hypertension and hyperglycaemia even in young patients",
              "Identifying VTE risk early allows timely prophylaxis during reduced mobility or hospitalisation"
            ]
          },
          {
            "treatment": "Initiation of disease-modifying therapy for multiple sclerosis if diagnostic criteria are subsequently met",
            "timing": "Delay",
            "reasons": [
              "Requires confirmation of dissemination in time and space on MRI and/or CSF before starting long-term therapy",
              "Choice of agent should follow multidisciplinary discussion in an MS service and incorporate patient preferences and risk profile"
            ]
          },
          {
            "treatment": "Long-term immunosuppressive therapy for neuromyelitis optica spectrum disorder or MOG-antibody\u2013associated disease (e.g., rituximab, azathioprine, mycophenolate mofetil)",
            "timing": "Delay",
            "reasons": [
              "Should only be commenced once antibody testing and imaging confirm NMOSD or MOGAD",
              "Requires pre-treatment infection screening and detailed counselling about risks and monitoring"
            ]
          },
          {
            "treatment": "Therapeutic plasma exchange",
            "timing": "Delay",
            "reasons": [
              "Reserved for severe optic neuritis with marked visual loss that fails to improve after 3\u20135 days of high-dose intravenous steroids",
              "Invasive therapy with significant resource use and risk, not indicated while vision is only moderately impaired and initial steroid response is unknown"
            ]
          },
          {
            "treatment": "Referral for visual rehabilitation services and low-vision aids if significant deficit persists",
            "timing": "Delay",
            "reasons": [
              "Appropriate only after the degree of permanent visual loss is clear following recovery period",
              "Helps optimise functional adaptation and quality of life if visual recovery is incomplete"
            ]
          }
        ],
        "steroids_evaluation": {
          "ft_plan": {
            "treatment": "Intravenous methylprednisolone 1 g daily for 3\u20135 days followed by a short oral prednisolone taper",
            "timing": "Start Now",
            "reasons": [
              "First-line therapy for acute inflammatory demyelinating optic neuritis",
              "Can hasten visual recovery even though final visual outcome may be similar without treatment",
              "Helps treat potential NMOSD or MOG-antibody\u2013associated optic neuritis where early immunosuppression is important",
              "No evidence from current data of active infection or other contraindications to high-dose steroids"
            ]
          },
          "gt_plan": {
            "treatment_inappropriate": true,
            "reasons": {
              "missing_information": [
                "No indication this isn't an exacerbation of an old deficit/pseudorelapse.",
                "A safety screen for patient-specific comorbidities is required to identify contraindications to immunosuppressive therapy."
              ],
              "contraindications": []
            }
          },
          "evaluation_summary": "Not appropriate to start treatment immediately.\n  \nCorrectly identified the following:\n\n- Need to know comorbidities to ensure no contraindications to immunosuppression.\n  \nAdditional factors not mentioned:\n\n- This could be a pseudorelapse (exacerbation of an old deficit) rather than a new acute inflammatory relapse, need further clarity in the history of presenting complaint."
        },
        "dmt_evaluation": {
          "ft_plan": {
            "treatment": "Initiation of disease-modifying therapy for multiple sclerosis if diagnostic criteria are subsequently met",
            "timing": "Delay",
            "reasons": [
              "Requires confirmation of dissemination in time and space on MRI and/or CSF before starting long-term therapy",
              "Choice of agent should follow multidisciplinary discussion in an MS service and incorporate patient preferences and risk profile"
            ]
          },
          "gt_plan": {
            "treatment_inappropriate": true,
            "reasons": {
              "missing_information": [
                "Need confirmation of MS diagnosis.",
                "A safety screen for patient-specific comorbidities is required to identify contraindications to immunosuppressive therapy."
              ],
              "contraindications": []
            }
          },
          "evaluation_summary": "Appropriate to consider but delay treatment.\n  \nCorrectly identified the following:\n\n- Need confirmation of MS diagnosis.\n  \nAdditional factors not mentioned:\n\n- Need to know comorbidities to ensure no contraindications to immunosuppression."
        }
      },
      "scoring": {
        "steroids": {
          "decision_category": "inappropriate_commission",
          "is_unsafe": 1,
          "reasons_total": 2,
          "reasons_acknowledged": 1,
          "reasons_missed": 1,
          "reasons_coverage_percentage": 0.5
        },
        "dmt": {
          "decision_category": "appropriate_caution",
          "is_unsafe": 0,
          "reasons_total": 2,
          "reasons_acknowledged": 1,
          "reasons_missed": 1,
          "reasons_coverage_percentage": 0.5
        }
      }
    }
  }
}